The Identification of Two Germ-line Mutations in the Human Breast Cancer Resistance Protein Gene that Result in the Expression of a Low/Non-functional Protein

By Yoshioka Sho   Katayama Kazuhiro   Okawa Chikako   Takahashi Sachiko   Tsukahara Satomi   Mitsuhashi Junko   Sugimoto Yoshikazu  

Pharmaceutical Research, Vol. 24, Iss. 6, 2007-06 ,pp. : 1108-1117

Springer Publishing Company

Access to resources Recommend Favorite

Identification of novel mutations by exome sequencing in African American colorectal cancer patients

By Ashktorab Hassan   Daremipouran Mohammad   Devaney Joe   Varma Sudhir   Rahi Hamed   Lee Edward   Shokrani Babak   Schwartz Russell   Nickerson Michael L.   Brim Hassan  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 34-42

Blackwell Publishing

Access to resources Recommend Favorite

A yeast two-hybrid, systems based approach for the identification of novel pharmaceutical entities

By Young K.H.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Identification of Novel Drug Targets for Angiostatic Cancer Therapy; It Takes Two to Tango

By  

Current Pharmaceutical Design, Vol. 13, Iss. 35, 2007-01 ,pp. : 3576-3583

Bentham Science Publishers

Access to resources Recommend Favorite

Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review

By Rahalkar Amit R.   Giffen Fiona   Har Bryan   Ho Josephine   Morrison Katherine M.   Hill John   Wang Jian   Hegele Robert A.   Joy Tisha  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 3, 2009-03 ,pp. : 151-160

NRC Research Press

Access to resources Recommend Favorite